Status:
UNKNOWN
Providers' Compliance to Malaria Treatment
Lead Sponsor:
Ifakara Health Institute
Collaborating Sponsors:
Swiss Tropical & Public Health Institute
KEMRI-Wellcome Trust Collaborative Research Program
Conditions:
Malaria
Eligibility:
All Genders
Phase:
NA
Brief Summary
INDEPTH Network Effectiveness and Safety Studies in Africa (INESS) have demonstrated a substantial efficacy decay of Artemisinin based combination therapy (ACT) in Tanzania in 2012 (from efficacy of 9...
Detailed Description
The baseline assessment of systems effectiveness performed by this team, have done a comprehensive quantitative documentation of efficacy decay for ACTs in real world settings; showing how community a...
Eligibility Criteria
Inclusion
- Dispensaries and health centers; public and private; operating in Rufiji district that provided outpatient services will be eligible for the study. In the intervention arm facility, all health workers who see and take care of patients at the outpatient department (OPD) will be registered to receive automated SMS as the intervention in this study.
- During the evaluation phase, all patients attending the surveyed facilities for initial illness consultation will be eligible for inclusion in the study. Assessment of adherence will be performed to malaria patients (who tested positive) and received ACT for treatment.
Exclusion
- Due to logistical difficulties, health facilities within the Delta region will be excluded in this study. As well, two hospitals in the district will be excluded in the study since they mostly receive referral patients. Also, hospitals have specialized clinic sections with highly trained staff and their nurses or clinicians may be rotating in different departments, hence there may not be health provider's whose primary duties are on OPD patients alone. In addition, health workers in eligible facilities who do not own a mobile phone will be excluded to receive "SMS" reminders.
- During evaluation, all severe cases and hospitalized patients will not be included in the surveys. Assessment of adherence study will exclude non residents of the study area.
- \-
Key Trial Info
Start Date :
November 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2015
Estimated Enrollment :
712 Patients enrolled
Trial Details
Trial ID
NCT02298140
Start Date
November 1 2014
End Date
December 1 2015
Last Update
August 3 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ifakara Health Institute
Rufiji, Coast Region, Tanzania